Transmyocardial CO2 laser revascularization improves symptoms, function, and quality of life: 12-month results from a randomized controlled trial
β Scribed by J.A. Spertus; P.G. Jones; M. Coen
- Book ID
- 114346956
- Publisher
- Elsevier Science
- Year
- 2002
- Tongue
- English
- Weight
- 38 KB
- Volume
- 11
- Category
- Article
- ISSN
- 1062-1458
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## Background and Objectives We assessed quality of life (QOL) after XeCl transmyocardial laser revascularization (TMLR). ## Study Design/Materials and Methods Thirty patients were randomized to receive XeCl excimer TMLR or optimal cardiac medication (controls). QOL was assessed at b
## Abstract As part of the first randomized, shamβtimulation controlled trial on deep brain stimulation (DBS) in primary segmental or generalized dystonia, healthβrelated quality of life (HRQoL) was assessed by SFβ36. After the 3βmonth shamβcontrolled phase, significant HRQoL improvement occurred o